157
Participants
Start Date
June 30, 2008
Primary Completion Date
January 15, 2009
Study Completion Date
January 15, 2009
Pneumococcal vaccine GSK2189242A
Two doses of 0.5 ml will be administered intramuscularly; one dose at Month 0 and another at Month 2. Six different formulations of this vaccine will be tested
Pneumo 23™
One dose of 0.5 ml will be administered intramuscularly at Month 0, and a placebo dose to keep the blinding at Month 2
GSK Investigational Site, Ghent
Lead Sponsor
GlaxoSmithKline
INDUSTRY